Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥16,585 | CN¥13,691 | CN¥14,238 | CN¥16,426 |
| - Cash | CN¥6,821 | CN¥6,864 | CN¥7,120 | CN¥6,999 |
| + Debt | CN¥8,933 | CN¥8,239 | CN¥8,396 | CN¥7,304 |
| Enterprise Value | CN¥18,697 | CN¥15,066 | CN¥15,514 | CN¥16,730 |
| Revenue | CN¥2,005 | CN¥2,195 | CN¥1,726 | CN¥1,734 |
| % Growth | -8.6% | 27.2% | -0.5% | – |
| Gross Profit | CN¥295 | CN¥180 | CN¥185 | -CN¥192 |
| % Margin | 14.7% | 8.2% | 10.7% | -11.1% |
| EBITDA | CN¥148 | CN¥275 | CN¥289 | -CN¥107 |
| % Margin | 7.4% | 12.5% | 16.7% | -6.2% |
| Net Income | CN¥41 | CN¥39 | CN¥13 | -CN¥190 |
| % Margin | 2.1% | 1.8% | 0.7% | -11% |
| EPS Diluted | 0.004 | 0.004 | 0.001 | -0.02 |
| % Growth | 5.3% | 216.7% | 106% | – |
| Operating Cash Flow | CN¥165 | CN¥200 | -CN¥53 | CN¥0 |
| Capital Expenditures | -CN¥201 | -CN¥139 | -CN¥331 | -CN¥571 |
| Free Cash Flow | -CN¥35 | CN¥61 | -CN¥386 | CN¥34 |